or
forgot password
  • cancer clinical trials in arkansas

  • Safety and Tolerability Study of SNS01-T in Relapsed or Refractory Multiple Myeloma, Mantle Cell Lymphoma, or Diffuse Large B Cell Lymphoma
    The University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Multiple Myeloma, Multiple Myeloma in Relapse, Refractory Multiple Myeloma, Mantle Cell Lymphoma in Relapse, Diffuse Large B Cell Lymphoma in Relapse
    Study of Hyperbaric Oxygen Therapy in Addition to Standard Growth Factor Support for Hematopoietic Progenitor/Stem Cell Mobilization
    University of Arkansas for Medical Science
    Little Rock, Arkansas 72205
    Multiple Myeloma
    Study of Gemcitabine + PEGPH20 vs Gemcitabine Alone in Stage IV Previously Untreated Pancreatic Cancer
    Highlands Oncology Group
    Springdale, Arkansas 72764
    Stage IV Pancreatic Cancer
    Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Leukemia, Pediatric
    Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Childhood Cerebral Astrocytoma/Malignant Glioma, Childhood High-grade Cerebellar Astrocytoma, Childhood High-grade Cerebral Astrocytoma, Childhood Infratentorial Ependymoma, Childhood Mixed Glioma, Childhood Oligodendroglioma, Childhood Supratentorial Ependymoma, Recurrent Childhood Cerebellar Astrocytoma, Recurrent Childhood Cerebral Astrocytoma, Recurrent Childhood Ependymoma, Recurrent Childhood Subependymal Giant Cell Astrocytoma
    Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) With Concomitant Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma (GBM)
    University of Arkansas Winthrop P. Rockefeller Cancer Institute
    Little Rock, Arkansas 72205
    Glioblastoma, GBM, Glioma, High Grade Glioma
    Genetic Analysis to Evaluate the Racial Difference in the Outcome of Patients With Colon Cancer
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Colon Cancer
    Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma, Glioblastoma With Oligodendroglial Component
    Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors
    Highlands Oncology Group Dept of Highlands Oncology Grp
    Fayetteville, Arkansas 72703
    Advanced Solid Tumors, Metastatic Breast Cancer, Metastatic Renal Cell Carcinoma
    A Study of Siltuximab (Anti- IL 6 Monoclonal Antibody) in Patients With High-risk Smoldering Multiple Myeloma

    Little Rock, Arkansas 72205-7199
    High-risk Smoldering Multiple Myeloma
    Phase 3 Papulopustular Rosacea Study
    Northwest AR Clinical Trials Center
    Rogers, Arkansas 72758
    Papulopustular Rosacea (PPR)
    Phase Ib/II Trial of BEZ235 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer
    Highlands Oncology Group
    Springdale, Arkansas 72764
    Inoperable Locally Advanced Breast Cancer, Metastatic Breast Cancer (MBC)
    S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer
    Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Childhood Hepatocellular Carcinoma, Papillary Thyroid Cancer, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Rhabdomyosarcoma, Recurrent Thyroid Cancer, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
    Analyzing the Composition of Tears and Blood for Discovery of Novel Signatures of Aggressive Prostate Cancer
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Prostate Cancer
    S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer
    Hembree Mercy Cancer Center at St. Edward Mercy Medical Center

    Trial Locations
    Hembree Mercy Cancer Center at St. Edward Mercy Medical Center
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Breast Cancer
    Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer
    Highlands Oncology Group Dept of Highlands Oncology Grp
    Fayetteville, Arkansas 72703
    Metastatic Breast Cancer
    Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
    Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences
    Little Rock, Arkansas 722205
    Hot Flashes, Breast Cancer
    Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Melanoma
    Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Neurofibromatosis Type 1, Recurrent Childhood Pilocytic Astrocytoma, Recurrent Childhood Visual Pathway Glioma
    Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck Cancer
    University of Arkansas
    Little Rock, Arkansas 72202
    Head and Neck Neoplasms
    An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease
    University of Arkanasas for Medical Sciences
    Little Rock, Arkansas 72205
    Cushing's Disease
    A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Little Rock, Arkansas 72205
    Neoplasms, Hematologic
    Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Diffuse Large Cell Lymphoma, L3 Childhood Acute Lymphoblastic Leukemia, Stage III Childhood Large Cell Lymphoma, Stage IV Childhood Large Cell Lymphoma, Untreated Childhood Acute Lymphoblastic Leukemia
    Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)
    Lynn Institute of the Ozarks

    Trial Locations
    Lynn Institute of the Ozarks
    Preferred Research Partners
    Obesity, Overweight
    A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
    Highlands Oncology Group Dept of Highlands Oncology Grp
    Fayetteville, Arkansas 72703
    Breast Cancer
    Engraftment Syndrome After Autologous Stem Cell Transplant: Retrospective Review in Patients With Multiple Myeloma
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Multiple Myeloma
    A Non-interventional Observational Study of Infectious Complications in Cancer Patients
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Aspergillosis, Candidemia, C. Difficile
    Effect of Metformin on Biomarkers of Colorectal Tumor Cell Growth
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    Central Arkansas Veterans Heathcare System
    Colorectal Neoplasms
    Photodynamic Therapy (PDT) With Temoporfin for Non-Resectable Non-Small-Cell Lung Cancer
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Carcinoma, Non-Small-Cell-Lung
    Afatinib Expanded Access Program
    1200.45.057 Boehringer Ingelheim Investigational Site

    Trial Locations
    1200.45.057 Boehringer Ingelheim Investigational Site
    1200.45.047 Boehringer Ingelheim Investigational Site
    Carcinoma, Non-Small-Cell Lung
    Study of BMS-936558 vs. Everolimus in Pre-Treated Advanced Or Metastatic Clear-cell RCC
    Local Institution
    Little Rock, Arkansas
    Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma
    LDK378 in Adult Patients With ALK-activated NSCLC Previously Treated With Chemotherapy and Crizotinib
    Highlands Oncology Group Dept of Highlands Oncology Grp
    Fayetteville, Arkansas 72703
    Non-Small Cell Lung Cancer
    LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer
    Highlands Oncology Group Dept of Highlands Oncology Grp
    Fayetteville, Arkansas 72703
    Non-Small Cell Lung Cancer
    Single Arm on the Tolerability of Weekly Nab-paclitaxel
    Highlands Oncology Group
    Springdale, Arkansas 72764
    Non Small Cell Lung Cancer (NSCLC)
    A Study of LY2940680 in Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Little Rock, Arkansas 72205
    Small Cell Lung Carcinoma
    Study Investigating a PEGylated Recombinant Factor VIII (BAX 855) for Hemophilia A (PROLONG-ATE Study)
    Arkansas Children's Hospital
    Little Rock, Arkansas 72202-3591
    Hemophilia A
    Candin Safety & Efficacy Study for the Treatment of Warts
    Johnson Dermatology
    Fort Smith, Arkansas 72916
    Warts, Human Papilloma Virus
    A Study of Necitumumab and Chemotherapy in Participants With Stage IV Squamous Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Little Rock, Arkansas 72205
    Squamous Non Small Cell Lung Cancer
    A Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab in the First-Line Treatment of Participants With Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Little Rock, Arkansas 72205
    Non-small Cell Lung Cancer
    Adjuvant Chemotherapy in Patients With High Risk Stage I Non-squamous Non-Small Cell Lung Cancer
    Highlands Oncology Group
    Springdale, Arkansas 72764
    Non-Small Cell Lung Cancer